| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |